Coccidioidomycosis

Coccidioidomycosis is a fungal infection caused by Coccidiodes. The fungus has a limited geographic distribution but the disease can be seen anywhere. Primary infection is usually self-limited; however, when a large dose of fungus is inhaled or in an immunosuppressed host, the patient may develop overwhelming infection, including ARDS, in a brief period. While serodiagnosis can help to suspect the diagnosis, particularly in the setting of overwhelming disease, diagnostic efforts should focus on identifying the organism in body fluids or tissues. Several treatment options are available. Amphotericin B was the drug of choice for decades when there were no alternatives. Triazoles, fluconazole and itraconazole, are very effective and much less toxic.

KEYWORDS

Coccidioidomycosis - valley fever - fungal infection - ARDS - antifungal agents

REFERENCES

• 1 Abuodeh R O, Galgiani J N, Scalarone G M. Molecular approaches to the study of Coccidioides immitis .  Int J Med Microbiol. 2002;  292 373-380
• 2 Campins H. Coccidioidomycosis in South America: a review of its epidemiology and geographic distribution.  Mycopathol Mycol Appl. 1970;  41 25-34
• 3 Drutz D J, Catanzaro A. State of the art. Coccidioidomycosis. Part II.  Am Rev Respir Dis. 1978;  117 727-771
• 4 Durry E, Pappagianis D, Werner S B et al.. Coccidioidomycosis in Tulare County, California, 1991: reemergence of an endemic disease.  J Med Vet Mycol. 1997;  35 321-326
• 5 Schneider E, Hajjeh R A, Spiegel R A et al.. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake.  JAMA. 1997;  277 904-908
• 6 Chaturvedi V, Ramani R, Gromadzki S, Rodeghier B, Chang H G, Morse D L. Coccidioidomycosis in New York State.  Emerg Infect Dis. 2000;  6 25-29
• 7 Cairns L, Blythe D, Kao A et al.. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico.  Clin Infect Dis. 2000;  30 61-64
• 8 Flynn N M, Hoeprich P D, Kawachi M M et al.. An unusual outbreak of windborne coccidioidomycosis.  N Engl J Med. 1979;  301 358-361
• 9 Catanzaro A. Pulmonary coccidioidomycosis.  Med Clin North Am. 1980;  64 461-473
• 10 Birsner J W. The roentgen aspects of five hundred cases of pulmonary coccidioidomycosis.  Am J Roentgenol Radium Ther Nucl Med. 1954;  72 556-573
• 11 Cunningham R T, Einstein H. Coccidioidal pulmonary cavities with rupture.  J Thorac Cardiovasc Surg. 1982;  84 172-177
• 12 Arsura E L, Bellinghausen P L, Kilgore W B, Abraham J J, Johnson R H. Septic shock in coccidioidomycosis.  Crit Care Med. 1998;  26 62-65
• 13 Cha J M, Jung S, Bahng H S et al.. Multi-organ failure caused by reactivated coccidioidomycosis without dissemination in a patient with renal transplantation.  Respirology. 2000;  5 87-90
• 14 Galgiani J N, Ampel N M, Catanzaro A, Johnson R H, Stevens D A, Williams P L. Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America.  Clin Infect Dis. 2000;  30 658-661
• 15 Ampel N M. Coccidioidomycosis among persons with human immunodeficiency virus infection in the era of highly active antiretroviral therapy (HAART).  Semin Respir Infect. 2001;  16 257-262
• 16 DiTomasso J P, Ampel N M, Sobonya R E, Bloom J W. Bronchoscopic diagnosis of pulmonary coccidioidomycosis. Comparison of cytology, culture, and transbronchial biopsy.  Diagn Microbiol Infect Dis. 1994;  18 83-87
• 17 Wallace J M, Catanzaro A, Moser K M, Harrell J H. Flexible fiberoptic bronchoscopy for diagnosing pulmonary coccidioidomycosis.  Am Rev Respir Dis. 1981;  123 286-290
• 18 Chitkara Y K. Evaluation of cultures of percutaneous core needle biopsy specimens in the diagnosis of pulmonary nodules.  Am J Clin Pathol. 1997;  107 224-228
• 19 Beard J S, Benson P M, Skillman L. Rapid diagnosis of coccidioidomycosis with a DNA probe to ribosomal RNA.  Arch Dermatol. 1993;  129 1589-1593
• 20 Pappagianis D. Serologic studies in coccidioidomycosis.  Semin Respir Infect. 2001;  16 242-250
• 21 Gade W, Ledman D W, Wethington R, Yi A. Serological responses to various Coccidioides antigen preparations in a new enzyme immunoassay.  J Clin Microbiol. 1992;  30 1907-1912
• 22 Antoniskis D, Larsen R A, Akil B, Rarick M U, Leedom J M. Seronegative disseminated coccidioidomycosis in patients with HIV infection.  AIDS. 1990;  4 691-693
• 23 Boddicker J H, Fong D, Walsh T E, Schillaci R F, Moniot A L, Catanzaro A. Bone and gallium scanning in the evaluation of disseminated coccidioidomycosis.  Am Rev Respir Dis. 1980;  122 279-287
• 24 Bouza E, Dreyer J S, Hewitt W L, Meyer R D. Coccidioidal meningitis: an analysis of thirty-one cases and review of the literature.  Medicine (Baltimore). 1981;  60 139-172
• 25 Drutz D J. Amphotericin B in the treatment of coccidioidomycosis.  Drugs. 1983;  26 337-346
• 26 Galgiani J N, Stevens D A, Graybill J R, Dismukes W E, Cloud G A. Ketoconazole therapy of progressive coccidioidomycosis: comparison of 400- and 800-mg doses and observations at higher doses.  Am J Med. 1988;  84(3 pt 2) 603-610
• 27 Catanzaro A, Galgiani J N, Levine B E et al.. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group.  Am J Med. 1995;  98 249-256
• 28 Graybill J R, Stevens D A, Galgiani J N, Dismukes W E, Cloud G A. Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group.  Am J Med. 1990;  89 282-290
• 29 Galgiani J N, Catanzaro A, Cloud G A et al.. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis: a randomized, double-blind trial. Mycoses Study Group.  Ann Intern Med. 2000;  133 676-686
• 30 Gonzalez G M, Tijerina R, Najvar L K et al.. Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.  Antimicrob Agents Chemother. 2001;  45 1854-1859
• 31 Cortez K J, Walsh T J, Bennett J E. Successful treatment of coccidioidal meningitis with voriconazole.  Clin Infect Dis. 2003;  36 1619-1622